Covered recipient · General Payments record
KARA J HOISINGTON
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$260,422.61
- Reported across 805 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $236.80 | 17 |
| Education | $13.76 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $167.31 | 13 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.43 | 1 |
| Lilly USA, LLC | $18.20 | 1 |
| IBSA Pharma Inc. | $16.75 | 1 |
| Averitas Pharma Inc. | $16.11 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Averitas Pharma Inc. | $16.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133429855 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086256266 | CMS |
| IBSA Pharma Inc. | $16.75 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142981547 | CMS |
| Lilly USA, LLC | $18.20 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135105387 | CMS |
| Novo Nordisk Inc | $11.29 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097038101 | CMS |
| Novo Nordisk Inc | $10.48 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097050569 | CMS |
| Novo Nordisk Inc | $14.65 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096944537 | CMS |
| Novo Nordisk Inc | $9.76 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097234872 | CMS |
| Novo Nordisk Inc | $6.20 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097501744 | CMS |
| Novo Nordisk Inc | $12.02 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096640550 | CMS |
| Novo Nordisk Inc | $11.56 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097173553 | CMS |
| Novo Nordisk Inc | $14.92 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096949592 | CMS |
| Novo Nordisk Inc | $22.88 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097228543 | CMS |
| Novo Nordisk Inc | $16.45 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097808975 | CMS |
| Novo Nordisk Inc | $12.66 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097580955 | CMS |
| Novo Nordisk Inc | $9.55 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900425 | CMS |
| Novo Nordisk Inc | $14.89 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096939945 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 05/14/2024 | Education | Undisputed | 01/23/2026 | 1137577858 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.